For families and patients wanting more information about Allo Phase 2 Alzheimer’s Clinical Trial: LEARN MORE

Troubled by hot flashes? Learn more about the HF Relief Study being conducted at the University of Arizona to test the effectiveness of a natural product, PhytoSERM, to alleviate hot flashes: hfrelief.org

For information about the PhytoSERM Brain Clinical Trial: LEARN MORE

Our mission: Create innovations in brain science of the future for those who need a cure today.

 

Our focus: Alzheimer’s, Parkinson’s, Multiple Sclerosis and ALS.

Vibrant brains that last a lifetime.

The Center for Innovation in Brain Science (CIBS) was created to address the challenge that, in the 21st century, there is not a single cure for a single neurodegenerative disease. Our unique “all brains on deck” collaborative research environment is an innovative academic/biotech hybrid, integrating expertise and team science to shift the research paradigm with patient-inspired and data-driven approaches to generate cures for Alzheimer’s, Multiple Sclerosis, Parkinson’s and ALS (Amyotrophic Lateral Sclerosis).

Our Focus Areas

Alzheimer’s Disease

Alzheimer’s Disease (AD) is the leading age-associated neurodegenerative disorder, affecting more than 50 million people globally. No therapies exist to prevent, delay or treat AD. Current therapies target cognitive function and provide modest short-term benefit while not affecting disease progression.

Learn more

Parkinson’s Disease

Parkinson’s disease is a brain disorder, causing nerve cells in an area of that brain that controls movement to become impaired and/or die. When impaired, these nerve cells or neurons produce less dopamine, which causes movement issues.

Learn more

Multiple Sclerosis (MS)

Multiple Sclerosis is a potentially disabling disease of the brain and the central nervous system, where the immune system attacks the protective sheath (myelin), resulting in communications challenges between the brain and the body.

Learn more

Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS) is a rapidly progressing, fatal neurodegenerative disorder. Deterioration of motor neurons results in the loss of voluntary movement control, and eventually breathing. The median life expectancy is three to five years after diagnosis.

Learn more

The Center for Innovation in Brain Science (CIBS) at the University of Arizona is addressing the challenge that, in the 21st century, there is not a single cure for a single neurodegenerative disease and is focused on four age-associated neurodegenerative diseases: Alzheimer’s, Parkinson’s, Multiple Sclerosis and ALS.

© 2024 Center for Innovation Brain Science. University of Arizona Health Sciences.

Skip to content